Mabwell will present six preclinical studies at the 2025 AACR Annual Meeting in Chicago, highlighting their expanding oncology pipeline with innovative antibody-drug conjugates and T-cell engagers.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.